Your browser is no longer supported. Please, upgrade your browser.
ABBV AbbVie Inc. daily Stock Chart
AbbVie Inc.
IndexS&P 500 P/E17.17 EPS (ttm)5.08 Insider Own0.07% Shs Outstand1.50B Perf Week-1.13%
Market Cap131.00B Forward P/E10.00 EPS next Y8.72 Insider Trans-20.82% Shs Float1.49B Perf Month2.67%
Income7.93B PEG1.01 EPS next Q1.93 Inst Own72.20% Short Float1.99% Perf Quarter-5.12%
Sales32.19B P/S4.07 EPS this Y-2.40% Inst Trans0.11% Short Ratio4.12 Perf Half Y-7.63%
Book/sh-1.93 P/B- EPS next Y9.63% ROA11.20% Target Price99.28 Perf Year-16.44%
Cash/sh5.85 P/C14.91 EPS next 5Y16.97% ROE- 52W Range77.50 - 125.86 Perf YTD-5.41%
Dividend4.28 P/FCF19.37 EPS past 5Y1.20% ROI17.80% 52W High-30.72% Beta1.39
Dividend %4.91% Quick Ratio1.10 Sales past 5Y9.00% Gross Margin76.30% 52W Low12.52% ATR2.61
Employees30000 Current Ratio1.20 Sales Q/Q17.70% Oper. Margin33.00% RSI (14)48.42 Volatility1.80% 3.12%
OptionableYes Debt/Eq- EPS Q/Q78.30% Profit Margin23.40% Rel Volume0.90 Prev Close87.20
ShortableYes LT Debt/Eq- EarningsJan 25 BMO Payout67.50% Avg Volume7.23M Price87.20
Recom2.70 SMA20-0.53% SMA50-0.80% SMA200-6.42% Volume0 Change0.00%
Jan-03-19Downgrade BofA/Merrill Buy → Neutral
Dec-26-18Initiated Standpoint Research Buy
Oct-22-18Reiterated SunTrust Buy $157 → $135
Oct-04-18Reiterated BofA/Merrill Buy $107 → $106
Jun-01-18Downgrade Piper Jaffray Overweight → Neutral
May-30-18Downgrade Credit Suisse Neutral → Underperform
Jan-30-18Reiterated Morgan Stanley Equal-Weight $99 → $131
Jan-29-18Downgrade Leerink Partners Outperform → Mkt Perform
Oct-30-17Reiterated Leerink Partners Outperform $108 → $107
Oct-02-17Upgrade Leerink Partners Mkt Perform → Outperform
Sep-25-17Downgrade UBS Buy → Neutral $79 → $92
Aug-17-17Initiated Evercore ISI Outperform $95
Jun-22-17Upgrade Societe Generale Hold → Buy
Mar-22-17Upgrade Societe Generale Sell → Hold
Oct-31-16Downgrade Credit Suisse Outperform → Neutral
Oct-18-16Initiated Leerink Partners Mkt Perform $70
Sep-08-16Downgrade JP Morgan Overweight → Neutral
Sep-02-16Initiated Raymond James Outperform $82
Jun-08-16Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-06-16Initiated Societe Generale Sell $47
Jan-17-19 11:49PM  Are you a Tortoise or a Hare Investor? Zacks
07:06PM  Pacira's Study on Exparel Label Expansion Meets Endpoints Zacks
09:15AM  Banks Keep Stocks Moving Higher Zacks
08:48AM  Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon Zacks
07:00AM  Trending: Investors Turn to Dividend Aristocrats Amid Market Volatility ETF Database
Jan-16-19 04:26PM  Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings Zacks
03:04PM  3 Healthcare Stocks That Will Keep Your Portfolio Healthy InvestorPlace
12:28PM  Will Dividend Stocks be the Hot Stocks of 2019? Zacks
06:26AM  Katz: Markets are looking past several negative headline... CNBC Videos
Jan-15-19 03:04PM  3 of the Top Big Pharma Stocks to Buy Now InvestorPlace
02:09PM  Drug companies greet 2019 with U.S. price hikes Reuters
Jan-14-19 06:00PM  Democrats target drug prices CNBC Videos
05:52PM  Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe Investor's Business Daily
04:08PM  U.S. lawmaker launches investigation into pharma drug pricing Reuters
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
07:57AM  Top Ranked Growth Stocks to Buy for January 14th Zacks
Jan-13-19 09:00AM  3 Top Dividend Stocks Selling at a Discount Right Now Motley Fool
Jan-11-19 05:36PM  5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019 Zacks
03:45PM  3 Back-of-the-Shelf Consumer Stocks With Growth and Income InvestorPlace
10:19AM  Top Ranked Momentum Stocks to Buy for January 11th Zacks
09:45AM  Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet Zacks
Jan-10-19 11:56PM  [$$] Senator Collins Presses HHS to Reform Drug Rebate System The Wall Street Journal
02:48PM  101 Best Dividend Stocks to Buy for 2019 and Beyond Kiplinger
11:51AM  6 High-Cap Stocks Paying High Dividend Yields
08:18AM  3 Dividend Stocks That Pay You Better Than Coca-Cola Does Motley Fool
08:15AM  3 Big Reasons Why AbbVie Isn't Worried About Humira Motley Fool
06:31AM  Top Ranked Momentum Stocks to Buy for January 10th Zacks
Jan-09-19 10:38AM  AbbVie Falls 3%
09:10AM  Is AbbVie (ABBV) a Great Value Stock Right Now? Zacks
08:48AM  The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy Zacks
08:31AM  Novartis' Crizanlizumab Gets Breakthrough Therapy Status Zacks
07:38AM  Inside look: LNG bunker that puts Jaxport on world map American City Business Journals
05:00AM  Top Picks 2019- AbbVie Inc. ABBV MoneyShow
Jan-08-19 02:27PM  Top Analyst Reports for Visa, Coca-Cola & AbbVie Zacks
Jan-07-19 05:45PM  AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know Zacks
05:18PM  Peninsula Alzheimer's fighter hunts $150 million IPO American City Business Journals
12:42PM  Neurocrine Gives Ingrezza Sales View, Updates on Pipeline Zacks
10:56AM  As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock InvestorPlace
09:09AM  Gilead (GILD) Collaborates With Yuhan for NASH Candidates Zacks
07:47AM  Jim Cramer Gives His Opinion On Ciena, Momo, Qualcomm And More Benzinga
07:15AM  Neurocrine Biosciences Is a Pharma Stock to Watch InvestorPlace
07:00AM  Today's Research Reports on Trending Tickers: AbbVie and Allergan ACCESSWIRE
04:00AM  The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie Zacks
Jan-06-19 06:01PM  3 Bargain Stocks You Can Buy Right Now Motley Fool
04:20PM  Abbvie: Time to Buy This Dividend Stock?
Jan-04-19 08:22PM  [$$] AbbVie to Record $4 Billion Impairment on Stemcentrx Assets The Wall Street Journal
07:04PM  Cramer's lightning round: 'Do some trimming' in Qualcomm ... CNBC Videos
06:50PM  Cramer's lightning round: 'Do some trimming' in Qualcomm if the stock rallies CNBC
06:09PM  AbbVie (ABBV) Inks Immunotherapy Deal with Private Biotech Zacks
05:11PM  Which Biopharma Stocks Are Looking To Score Big In Cannabis Medicine? Investor's Business Daily
10:07AM  Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate Zacks
08:08AM  AbbVie Rises 3%
07:29AM  Pfizer Begins Pivotal Study on Alopecia Areata Candidate Zacks
Jan-03-19 04:13PM  Bristol-Myers Angles To Become Mega-Pharma With $74 Billion Celgene Bid Investor's Business Daily
12:35PM  3 Biopharma Stocks to Buy for Their Robust Dividend Yields InvestorPlace
10:24AM  Bristol-Myers Angles To Become Mega-Pharma With $74 Billion Celgene Bid Investor's Business Daily
10:12AM  Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019? Zacks
08:30AM  AbbVie and Tizona Therapeutics Announce Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39 PR Newswire
08:16AM  AbbVie Falls 3%
08:04AM  3 Big Stock Charts for Thursday: Medtronic, Facebook and eBay InvestorPlace
08:00AM  AbbVie to Host Fourth-Quarter and Full-Year 2018 Earnings Conference Call PR Newswire
Jan-02-19 01:53PM  Drug companies greet 2019 with U.S. price hikes Reuters
01:29PM  Drug companies greet 2019 with U.S. price hikes Reuters
01:03PM  Stay with IBM? What's up with Blackstone? That and more i... CNBC Videos
04:52AM  AbbVie Falls 3%
Dec-31-18 05:45PM  AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know Zacks
08:49AM  The Most Promising Biotech Names Heading Into 2019 Investopedia
Dec-28-18 02:49PM  AbbVie: A Low-Risk Income Stock That Gives Investors Exposure to the Marijuana Industry
10:11AM  2019 biotech preview: Money is pouring into the Bay Area and so is Big Pharma American City Business Journals
09:58AM  AbbVie Rises 3%
09:46AM  Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019? Zacks
Dec-27-18 01:50PM  The Humira Overhang Cant Cast a Shadow on AbbVie Stock Forever InvestorPlace
09:35AM  AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV InvestorPlace
Dec-26-18 01:25PM  Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players? Investor's Business Daily +5.80%
10:04AM  AbbVie Partners Lupin to Boost Hematological Cancer Pipeline Zacks
05:18AM  AbbVie Rises 3%
Dec-24-18 05:45PM  AbbVie (ABBV) Stock Moves -0.89%: What You Should Know Zacks
Dec-22-18 12:00PM  Better Buy: AbbVie vs. Merck Motley Fool
Dec-21-18 02:52PM  AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib Zacks
Dec-20-18 05:59PM  Gilead Partners with Scholar Rock for Fibrotic Disease Drugs Zacks
05:18PM  AbbVie Rises 3%
08:50AM  AbbVie Submits New Drug Application to U.S. FDA and Marketing Authorization Application to EMA for Upadacitinib for Treatment of Adults with Moderate to Severe Rheumatoid Arthritis PR Newswire
08:00AM  AbbVie to Present at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire
06:00AM  3 Top Healthcare Stocks to Buy in December Motley Fool
Dec-19-18 12:45PM  This High-Yield Dividend Stock Could Outperform If the Stock Market Rallies
10:48AM  Why Eli Lilly Stock Is Still Shining in the Darkness InvestorPlace
07:05AM  Today's Research Reports on Trending Tickers: Dr. Reddy's Laboratories and AbbVie ACCESSWIRE
Dec-18-18 10:00AM  Lilly's Taltz Outshines Humira in Psoriatic Arthritis Study Zacks
09:58AM  The Zacks Analyst Blog Highlights: McDonald???s, AbbVie, Altria, Wells Fargo and Disney Zacks
Dec-17-18 05:45PM  AbbVie (ABBV) Stock Moves -0.79%: What You Should Know Zacks
09:00AM  AbbVie Announces Executive Leadership Changes PR Newswire
06:48AM  Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial Reuters
Dec-14-18 07:13PM  [$$] Companies Ramp Up Stock Buybacks as Market Swoon Continues The Wall Street Journal
12:27PM  AbbVie May Yield More Than It Appears
Dec-13-18 01:00PM  AbbVie Announces $5 Billion Increase to Stock Repurchase Program PR Newswire
Dec-12-18 10:51AM  5 Pharma Stocks That Could Cure Ailing Portfolios in 2019 InvestorPlace
05:00AM  AbbVie- High Yield at a Low Valuation MoneyShow
Dec-11-18 03:55PM  Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO Zacks
02:20PM  7 Stocks Wall Street Is Souring on Right Now Kiplinger
09:51AM  Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800 Zacks
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune diseases; IMBRUVICA, an oral therapy for treating chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid for hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product for human use; and ZINBRYTA, a treatment for relapsing forms of multiple sclerosis. It serves wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has collaborations with Alector, Inc.; C2N Diagnostics; Voyager Therapeutics, Inc.; Janssen Biotech, Inc.; International Myeloma Foundation; Calibr and Scripps Research; The Institute for Research in Immunology and Cancer Commercialization of Research; the Universite de Montreal; Tolero Pharmaceuticals, Inc.; Galapagos; Mission Therapeutics Ltd; Bristol-Myers Squibb Company; and Voluntis. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schumacher Laura JVice ChairmanDec 28Sale90.0025,0002,250,000134,322Jan 02 04:49 PM
CHASE WILLIAM JEVP, Finance & AdministrationDec 12Sale90.0060,0005,400,000104,863Dec 14 05:12 PM
GONZALEZ RICHARD AChairman of the Board and CEODec 11Sale88.7516,8501,495,438286,203Dec 13 04:56 PM
Schumacher Laura JExecutive Vice PresidentDec 04Option Exercise51.4294,1404,840,679192,398Dec 07 05:15 PM
Schumacher Laura JExecutive Vice PresidentDec 04Sale93.5894,1408,809,55298,258Dec 07 05:15 PM
Gosebruch Henry OEVP, Chief Strategy OfficerNov 29Sale90.1042,4503,824,94030,350Nov 30 05:22 PM
SEVERINO MICHAELEVP, R&D and CSOAug 17Sale97.5250,0004,876,06082,281Aug 21 04:58 PM
TILTON GLENN FDirectorJun 27Buy91.905,400496,27439,735Jun 29 02:30 PM
RAPP EDWARD JDirectorJun 20Buy98.631,01399,90920,743Jun 22 05:56 PM
ALBAN CARLOSEVP, Commercial OperationsMar 01Option Exercise29.2348,1001,405,795178,547Mar 02 05:29 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 01Option Exercise25.9132,400839,339197,263Mar 02 05:28 PM
ALBAN CARLOSEVP, Commercial OperationsMar 01Sale114.3980,9959,264,80897,552Mar 02 05:29 PM
Schumacher Laura JExecutive Vice PresidentMar 01Sale117.8525,0002,946,14898,317Mar 02 05:28 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 01Sale114.5032,4003,709,687164,863Mar 02 05:28 PM
Michael Robert A.VP, ControllerFeb 28Sale119.434,294512,8536,876Mar 02 05:31 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 28Sale117.771,337157,45893,312Mar 02 05:31 PM
SEVERINO MICHAELEVP, R&D and CSOFeb 28Sale117.932,643311,684132,281Mar 02 05:30 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 28Sale118.6718,1292,151,45217,588Mar 02 05:30 PM
CHASE WILLIAM JEVP, Chief Financial OfficerFeb 28Sale119.4438,5284,601,954164,863Mar 02 05:28 PM
ALBAN CARLOSEVP, Commercial OperationsFeb 28Sale117.852,579303,928130,447Mar 02 05:29 PM
GONZALEZ RICHARD AChairman of the Board and CEOFeb 28Sale117.888,280976,084313,012Mar 02 05:28 PM
Michael Robert A.VP, ControllerFeb 20Sale120.31992119,35113,557Feb 20 06:08 PM